How proteins are imported into human mitochondria? Many mitochondrial proteins utilize the TIM23 complex for their translocation. Prof. Agnieszka Chacińska and her team showed high conservation of the human TIM23 translocase when compared to highly studied yeast. Klaudia Maruszczak and Piotr Draczkowski used computational tools to get first architectural insights into protein transport into mitochondria […]

Work with us at IMol – we have a few openings! Join us to work in the topics of: -> immunological epigenetics (Paweł Mikulski) – postdoc position -> mitochondria and viruses (Michał Wasilewski/Agnieszka Chacińska) – postdoc position as a postdoctoral researcher or -> RNA biology (Magda Konarska) – PhD student Go to https://www.imol.institute/career-lab to find out […]

We are looking for experienced researchers to develop their own independent groups at our modern and science-friendly facility. We offer furnished laboratory space with access to state-of-the-art technology, excellent core facility and supportive administration. The deadline for applying is August 5th. Read more at https://www.imol.institute/group-leader-positions.

Latest commentary on splicing vulnerability in spliceosome-mutated blood malignancies published in Trends in Biochemical Sciences. IMol Group leader Dr. Maciej Cieśla and Dr. Cristian Bellodi from Lund University Stem Cell Center discuss new findings from the Abdel-Wahab and Bradley labs published in Molecular Cell. Link to the commentary: https://authors.elsevier.com/…/S0968-0004(24)00111-7 Link to the original paper: https://www.sciencedirect.com/…/pii/S1097276524002843…

oin our next edition of IMol Science Club with Prof. Lynne Maquat. Lynne is a Director of the Center of RNA Biology. MaquatLab studiesRNA decay pathways. In her lecture Lynne will talk about nonsense-mediated mRNA decay in human health and disease. Date: June 12th at 2 pm Venue: M. Flisa 6, Warsaw, Poland Host: Piotr […]

We are glad to announce that Dr. Monika Kluzek, who will soon join IMol as a Group Leader, has been awarded the NCN OPUS 26 Grant. The funding will allow her to realize the project which studies intratumoral bacteria that work with cancer cells, reducing the effectiveness of chemotherapy. As Monika says: “We plan to […]